Receptor-mediated mechanisms of lipoprotein remnant catabolism

被引:57
作者
Chappell, DA [1 ]
Medh, JD [1 ]
机构
[1] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
关键词
D O I
10.1016/S0163-7827(98)00017-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chylomicron and VLDL are triglyceride-rich lipoprotein particles assembled by the intestine and liver respectively. These particles are not metabolized by the liver in their native form. However, upon entry into the plasma, their triglyceride component is rapidly hydrolyzed by lipoprotein lipase and they are converted to cholesterol-rich remnant particles, The remnant particles are recognized by the liver and rapidly cleared from the plasma. This process is believed to occur in two steps. (i) An initial sequestration of remnant particles on hepatic cell surface proteoglycans, and (ii) receptor-mediated endocytosis of remnants by hepatic parenchymal cells. The initial binding to proteoglycans may be facilitated by lipoprotein lipase and hepatic lipase which possess both lipid- and heparin-binding domains. The subsequent endocytic process may be mediated by LDL receptors and/or LRP. Both receptors have a high affinity for apoE, a major apolipoprotein component of remnant particles. The lipases may also serve as ligands for these receptors. An impairment of any component of this complex process may result in an accumulation of remnant particles in the plasma leading to atherosclerosis and coronary heart disease. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:393 / 422
页数:30
相关论文
共 259 条
[1]   MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN-(APO)-CIII TRANSGENIC MICE - DIMINISHED VERY LOW-DENSITY-LIPOPROTEIN FRACTIONAL CATABOLIC RATE ASSOCIATED WITH INCREASED APO-CIII AND REDUCED APO-E ON THE PARTICLES [J].
AALTOSETALA, K ;
FISHER, EA ;
CHEN, XL ;
CHAJEKSHAUL, T ;
HAYEK, T ;
ZECHNER, R ;
WALSH, A ;
RAMAKRISHNAN, R ;
GINSBERG, HN ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1889-1900
[2]  
Allan CM, 1996, J LIPID RES, V37, P1510
[3]   REGULATION OF HEPATIC LIPOPROTEIN RECEPTORS IN THE DOG - RAPID REGULATION OF APOLIPOPROTEIN-B, APOLIPOPROTEIN-E RECEPTORS, BUT NOT OF APOLIPOPROTEIN-E RECEPTORS, BY INTESTINAL LIPOPROTEINS AND BILE-ACIDS [J].
ANGELIN, B ;
RAVIOLA, CA ;
INNERARITY, TL ;
MAHLEY, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (04) :816-831
[4]  
ARBEENY CM, 1984, J BIOL CHEM, V259, P9662
[5]   THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR MEDIATES THE CELLULAR CATABOLISM OF LIPOPROTEIN-LIPASE AND UROKINASE-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-I COMPLEXES [J].
ARGRAVES, KM ;
BATTEY, FD ;
MACCALMAN, CD ;
MCCRAE, KR ;
GAFVELS, M ;
KOZARSKY, KF ;
CHAPPELL, DA ;
STRAUSS, JF ;
STRICKLAND, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26550-26557
[6]   LARGE BUOYANT LDL-LIKE PARTICLES IN HEPATIC LIPASE DEFICIENCY [J].
AUWERX, JH ;
MARZETTA, CA ;
HOKANSON, JE ;
BRUNZELL, JD .
ARTERIOSCLEROSIS, 1989, 9 (03) :319-325
[7]  
AVIRAM M, 1988, J BIOL CHEM, V263, P15416
[8]  
BARRANS A, 1994, J BIOL CHEM, V269, P11572
[9]   RECEPTORS FOR TRIGLYCERIDE-RICH LIPOPROTEINS AND THEIR ROLE IN LIPOPROTEIN METABOLISM [J].
BEISIEGEL, U .
CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (03) :117-122
[10]   THE LDL RECEPTOR RELATED PROTEIN, LRP, IS AN APOLIPOPROTEIN-E-BINDING PROTEIN [J].
BEISIEGEL, U ;
WEBER, W ;
IHRKE, G ;
HERZ, J ;
STANLEY, KK .
NATURE, 1989, 341 (6238) :162-164